Creditors and court approve Danish pharma restructuring
Credit: Shutterstock/ studio formfrei
Copenhagen-based biopharmaceutical company Orphazyme has secured creditor and court approval of its restructuring proposal in Denmark, paving the way for it to sell its assets to US pharma group KemPharm.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Subscribe now